It sounds almost too simple, but simple is the point
Discussing these barriers with your PlexusDx provider can unlock solutions like simplified injection kits, auto-refill programs, or alternative formulations (oral semaglutide) that fit your lifestyle better
GLP-1 enhances glucose-stimulated insulin secretion, suppresses glucagon, delays gastric emptying, and promotes satiety through central appetite pathways [27]
Other GLP-1s have not listed dysesthesia as an adverse effect
What Ongoing Research May Clarify A PL 14736 trial (PL 14736 is the pharmaceutical-grade formulation of BPC-157 developed for clinical investigation) was listed on ClinicalTrials.gov for inflammatory bowel disease, though results have not been published as of May 2026 15
Another reason GLP-1s may impact levothyroxine is the drugs weight loss effect